{"nctId":"NCT04732624","briefTitle":"Enteral Resuscitation Nepal (Pilot Study)","startDateStruct":{"date":"2021-09-30","type":"ACTUAL"},"conditions":["Burn Body Region Unspecified","Burn Shock"],"count":30,"armGroups":[{"label":"Enteral-based Protocolized Resuscitation","type":"EXPERIMENTAL","interventionNames":["Drug: Oral Rehydration Solution","Drug: Lactated Ringer"]},{"label":"Intravenous Fluid Protocolized Resuscitation","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Lactated Ringer"]}],"interventions":[{"name":"Oral Rehydration Solution","otherNames":["Enteral-based Resuscitation"]},{"name":"Lactated Ringer","otherNames":["Intravenous Fluid Resuscitation"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* All genders\n* Adults aged â‰¥18 years who present with moderate-sized burn injuries \\[20 - 40% total body surface areas (TBSA)\\] to the Nepal Cleft and Burn Center within 24 hours of injury.\n\nExclusion Criteria:\n\n* Patients with electrical burns, chemical burns, inhalation injury.\n* Patients in overt shock (defined as serum lactate \\>2.5, or hypotension and altered mental status).\n* Pregnant patients, psychiatrically unstable patients will be excluded.\n* Patients with oropharyngeal defects and/or previously known diagnoses leading to high risk of aspiration, and/or precluding safe nasal-enteric access will be excluded.\n* Patients will history of chronic nausea and/or vomiting, including those with a diagnosis of gastroparesis due to diabetes mellitus will be excluded.\n* Patients with a Baux score of over 100 (age + TBSA), patients with declared palliative intent on admission, and patients for whom clinicians have high level of clinical concern based on clinical judgement will also be excluded.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"24 Hour Average Urine Output (UOP)","description":"Calculated by totaling all of the recorded urine output (adding up the columns labelled HR 1-2 UO, HR 3-4 UO, etc. until HR 23-24), then dividing by their weight in Kg (column labelled Admission weight) and dividing by 24 hours. The units of this measurement will be mL/kg/hr.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.7","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"PRIMARY","title":"24-hour Resuscitation Volume","description":"Calculated by totaling the total resuscitative fluids administered in first 24 hours of resuscitation, divided by admission weight and % TBSA of burn injury. (cc/kg/% TBSA of burn injury)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.7","spread":null},{"groupId":"OG001","value":"4.1","spread":null}]}]}]},{"type":"PRIMARY","title":"Hours From Injury to Resuscitation","description":"Hours calculated from point of injury to starting of resuscitation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.5","spread":null},{"groupId":"OG001","value":"13.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With GI Discomfort","description":"Any \"check\" for nausea, vomiting, distention, diarrhea","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Crossover to IV Due to GI Intolerance","description":"Number of participants crossover to standard of care (IV resuscitation) due to GI intolerance like nausea, vomitting","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Acute Kidney Injury","description":"Measured with any signs of Acute Kidney injury during first 72 hours of resuscitation according to KDIGO definition i.e., increase in serum creatinine by 0.3mg/dL or more within 48 hours or increase in serum creatinine to 1.5 times baseline or more within the last 7 days or urine output less than 0.5 mL/kg/h for 6 hours. AKI on admission was defined as a serum creatinine greater than 1.5 mg/dL with less than 0.5 mL/kg/h of urine output for the first hour. Urine output was measured every 2 hours for the first 24 hours and serum creatinine was measured on admission then 8,16,24,48 and 72 hours from the commencement of the resuscitation.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Participants Death Within 72 Hours of Resuscitation","description":"Secondary resuscitation outcome measured daily within study period i.e. 72 hours of resuscitation as participant death related or associated with the study. Monitored by data safety monitoring board and if proven to be associated with the study considered serious adverse event.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Discharge Outcome","description":"Outcome of hospital stay","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":15},"commonTop":["GI discomfort during resuscitation"]}}}